Technology: Neurological Disorders
Industry: Gene Therapy
Headquarters: London, England, United Kingdom
Founded Date: 2013
Employees Number: 11-50
Funding Status: M&A
Investors Number: 4
Total Funding: $174.6M
Estimated Revenue: $1M to $10M
Last Funding Type: Post-IPO Equity

Visit Website
enquiries@nightstarx.com
https://twitter.com/nightstar_x
Register and Claim Ownership